Turn Therapeutics appoints Robert R. Redfield as Chief Scientific Officer
Turn Therapeutics Inc. announced the appointment of Robert R. Redfield, M.D., as Chief Scientific Officer. The company is a clinical-stage biotech focused on targeted, non-systemic therapies for inflammatory and infectious skin diseases.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.